Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 200

1.

Heart rate on admission independently predicts in-hospital mortality in acute ischemic stroke patients.

Erdur H, Scheitz JF, Grittner U, Laufs U, Endres M, Nolte CH.

Int J Cardiol. 2014 Jul 11. pii: S0167-5273(14)01191-7. doi: 10.1016/j.ijcard.2014.07.001. [Epub ahead of print]

PMID:
25049007
[PubMed - as supplied by publisher]
2.

Risk prediction with triglycerides in patients with stable coronary disease on statin treatment.

Werner C, Filmer A, Fritsch M, Groenewold S, Gräber S, Böhm M, Laufs U.

Clin Res Cardiol. 2014 Jul 11. [Epub ahead of print]

PMID:
25012240
[PubMed - as supplied by publisher]
3.

Understanding IMPROVE-IT and the cardinal role of LDL-C lowering in CVD prevention.

Laufs U, Descamps OS, Catapano AL, Packard CJ.

Eur Heart J. 2014 Jun 10. pii: ehu228. [Epub ahead of print] Review. No abstract available.

PMID:
24917645
[PubMed - as supplied by publisher]
4.

[New AHA and ACC guidelines on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk : Statement of the D•A•CH Society for Prevention of Cardiovascular Diseases, the Austrian Atherosclerosis Society and the Working Group on Lipids and Atherosclerosis (AGLA) of the Swiss Society for Cardiology].

Klose G, Beil FU, Dieplinger H, von Eckardstein A, Föger B, Gouni-Berthold I, Koenig W, Kostner GM, Landmesser U, Laufs U, Leistikow F, März W, Merkel M, Müller-Wieland D, Noll G, Parhofer KG, Paulweber B, Riesen W, Schaefer JR, Steinhagen-Thiessen E, Steinmetz A, Toplak H, Wanner C, Windler E.

Internist (Berl). 2014 May;55(5):601-6. doi: 10.1007/s00108-014-3492-z. German.

PMID:
24770979
[PubMed - in process]
5.

Risk prediction with proprotein convertase subtilisin/kexin type 9 (PCSK9) in patients with stable coronary disease on statin treatment.

Werner C, Hoffmann MM, Winkler K, Böhm M, Laufs U.

Vascul Pharmacol. 2014 Aug;62(2):94-102. doi: 10.1016/j.vph.2014.03.004. Epub 2014 Mar 29.

PMID:
24685817
[PubMed - in process]
6.

The relationships of phytosterols and oxyphytosterols in plasma and aortic valve cusps in patients with severe aortic stenosis.

Schött HF, Luister A, Husche C, Schäfers HJ, Böhm M, Plat J, Lütjohann D, Laufs U, Weingärtner O.

Biochem Biophys Res Commun. 2014 Apr 11;446(3):805-10. doi: 10.1016/j.bbrc.2014.03.007. Epub 2014 Mar 12.

PMID:
24631689
[PubMed - in process]
7.

New AHA and ACC guidelines on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk.

Klose G, Beil FU, Dieplinger H, von Eckardstein A, Föger B, Gouni-Berthold I, Heigl F, Koenig W, Kostner GM, Landmesser U, Laufs U, Leistikow F, März W, Noll G, Parhofer KG, Paulweber B, Riesen WF, Schaefer JR, Steinhagen-Thiessen E, Steinmetz A, Toplak H, Wanner C, Windler E.

Wien Klin Wochenschr. 2014 Mar;126(5-6):169-75. doi: 10.1007/s00508-014-0513-9. Epub 2014 Mar 11.

PMID:
24615676
[PubMed - in process]
8.

Systems genetics of liver fibrosis: identification of fibrogenic and expression quantitative trait loci in the BXD murine reference population.

Hall RA, Liebe R, Hochrath K, Kazakov A, Alberts R, Laufs U, Böhm M, Fischer HP, Williams RW, Schughart K, Weber SN, Lammert F.

PLoS One. 2014 Feb 28;9(2):e89279. doi: 10.1371/journal.pone.0089279. eCollection 2014.

PMID:
24586654
[PubMed - in process]
Free PMC Article
9.

The mineralocorticoid receptor promotes fibrotic remodeling in atrial fibrillation.

Lavall D, Selzer C, Schuster P, Lenski M, Adam O, Schäfers HJ, Böhm M, Laufs U.

J Biol Chem. 2014 Mar 7;289(10):6656-68. doi: 10.1074/jbc.M113.519256. Epub 2014 Jan 27.

PMID:
24469458
[PubMed - indexed for MEDLINE]
10.

[Treatment of lipid disorders].

Custodis F, Laufs U.

Herz. 2014 Feb;39(1):119-28; quiz 129-30. doi: 10.1007/s00059-013-4013-x. German.

PMID:
24469010
[PubMed - in process]
11.

The dual PPARα/γ agonist aleglitazar increases the number and function of endothelial progenitor cells: implications for vascular function and atherogenesis.

Werner CM, Schirmer SH, Gensch C, Pavlickova V, Pöss J, Wright MB, Böhm M, Laufs U.

Br J Pharmacol. 2014 May;171(10):2685-703. doi: 10.1111/bph.12608.

PMID:
24467636
[PubMed - in process]
12.

Effects of renal sympathetic denervation on exercise blood pressure, heart rate, and capacity in patients with resistant hypertension.

Ewen S, Mahfoud F, Linz D, Pöss J, Cremers B, Kindermann I, Laufs U, Ukena C, Böhm M.

Hypertension. 2014 Apr;63(4):839-45. doi: 10.1161/HYPERTENSIONAHA.113.01985. Epub 2014 Jan 13.

PMID:
24420550
[PubMed - indexed for MEDLINE]
13.

Improvements in left ventricular hypertrophy and diastolic function following renal denervation: effects beyond blood pressure and heart rate reduction.

Schirmer SH, Sayed MM, Reil JC, Ukena C, Linz D, Kindermann M, Laufs U, Mahfoud F, Böhm M.

J Am Coll Cardiol. 2014 May 13;63(18):1916-23. doi: 10.1016/j.jacc.2013.10.073. Epub 2013 Dec 4.

PMID:
24315919
[PubMed - indexed for MEDLINE]
14.

Association of vitamin D status and blood pressure response after renal denervation.

Pöss J, Mahfoud F, Ukena C, Esler MD, Schlaich M, Hering D, Cremers B, Laufs U, Böhm M.

Clin Res Cardiol. 2014 Jan;103(1):41-7. doi: 10.1007/s00392-013-0621-y. Epub 2013 Oct 31.

PMID:
24173883
[PubMed - in process]
15.

Orthostatic function after renal sympathetic denervation in patients with resistant hypertension.

Lenski M, Mahfoud F, Razouk A, Ukena C, Lenski D, Barth C, Linz D, Laufs U, Kindermann I, Böhm M.

Int J Cardiol. 2013 Nov 30;169(6):418-24. doi: 10.1016/j.ijcard.2013.10.017. Epub 2013 Oct 12.

PMID:
24157238
[PubMed - in process]
16.

Plant sterols the better cholesterol in Alzheimer's disease? A mechanistical study.

Burg VK, Grimm HS, Rothhaar TL, Grösgen S, Hundsdörfer B, Haupenthal VJ, Zimmer VC, Mett J, Weingärtner O, Laufs U, Broersen LM, Tanila H, Vanmierlo T, Lütjohann D, Hartmann T, Grimm MO.

J Neurosci. 2013 Oct 9;33(41):16072-87. doi: 10.1523/JNEUROSCI.1506-13.2013.

PMID:
24107941
[PubMed - indexed for MEDLINE]
Free Article
17.

Drug adherence in patients taking oral anticoagulation therapy.

Ewen S, Rettig-Ewen V, Mahfoud F, Böhm M, Laufs U.

Clin Res Cardiol. 2014 Mar;103(3):173-82. doi: 10.1007/s00392-013-0616-8. Epub 2013 Sep 3.

PMID:
23999974
[PubMed - in process]
18.

Targeting the proprotein convertase subtilisin/kexin type 9 for the treatment of dyslipidemia and atherosclerosis.

Urban D, Pöss J, Böhm M, Laufs U.

J Am Coll Cardiol. 2013 Oct 15;62(16):1401-8. doi: 10.1016/j.jacc.2013.07.056. Epub 2013 Aug 21. Review.

PMID:
23973703
[PubMed - indexed for MEDLINE]
19.

Rac1-mediated effects of HMG-CoA reductase inhibitors (statins) in cardiovascular disease.

Adam O, Laufs U.

Antioxid Redox Signal. 2014 Mar 10;20(8):1238-50. doi: 10.1089/ars.2013.5526. Epub 2013 Sep 19.

PMID:
23919665
[PubMed - in process]
20.

Effects of nonpersistence with medication on outcomes in high-risk patients with cardiovascular disease.

Böhm M, Schumacher H, Laufs U, Sleight P, Schmieder R, Unger T, Teo K, Yusuf S.

Am Heart J. 2013 Aug;166(2):306-314.e7. doi: 10.1016/j.ahj.2013.04.016. Epub 2013 Jun 24.

PMID:
23895814
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk